Mitochondria and resilience in gynecologic cancer
Treatments studied
Part of Cancer clinical trials.
This study looks at how cell energy (mitochondria) relates to a person's ability to bounce back during treatment for advanced ovarian or endometrial cancer. If you qualify, you'll have tissue and blood samples analyzed alongside standard therapy to help find why some people handle treatment better than others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older
- You have newly diagnosed stage II, III, or IV ovarian, primary peritoneal, fallopian tube, or endometrial cancer
- Your cancer treatment plan includes chemotherapy before and/or after surgery
- You can read and understand English
- You have not had treatment for ovarian or endometrial cancer before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special exercise program during chemotherapy before surgery. It may help patients with certain gynecologic cancers get stronger and better prepared for treatment.
This study uses a safe, non-invasive light sensor (near-infrared spectroscopy) to measure how well your muscles use oxygen. Researchers want to learn if this tool can help monitor muscle health in people with breast or gynecological cancer that has not spread to other parts of the body.
This trial tests a personalized approach to treating advanced ovarian or endometrial cancers that have come back or stopped responding to standard treatments. It uses a special model to guide which therapy might work best for you.
This study tests a program to help gynecologic cancer patients who are frail improve their physical function and quality of life during treatment. It aims to see if extra support can help you stay stronger and recover better.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This trial studies simple “frailty” assessments (tests of strength, memory, and daily functioning) to better predict risk in people with gynecologic cancers who are planning or having surgery. If you qualify, the results may help doctors identify who needs extra support before and after surgery.
Hear when a new Gynecologycal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.